10 Mice Tested for FDA Booster Authorization for 2023/2024

Let’s Review the Process for FDA Booster Authorization for 2023/2024 Let’s review the approach FDA took to authorize/approve the monovalent boosters for 2023 fall season. It is interesting to see the vaccine efficacy duration and the data used to get the authorization. If you like this content and want more, I am doing a special lifetime membership offer. Click here: Want to support this work?: Buy me a coffee :-) Become my patron: PayPal: My substack: #drbeen #koolbeens #COVID Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. URL list from Thursday, Sep. 14 2023 Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Announcement - 06/15/2023 | FDA Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Briefing Document- FDA Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Presentation- CDC: COVID19 vaccine effectiveness updates Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Presentation- Pfizer: 2023-2024 COVID19 Vaccine Formula- Clinical and Preclinical Supportive Data Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Presentation- Novavax: Data in Support of 2023-2024 Vaccine Update FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants | FDA
Back to Top